Fluorescent reporters for real time single cell Pol III transcription measurement
Award amount
$176,165Program and phase
SBIR · Phase IAward year
2017Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- LUCERNA INC
- Proposal award date
- 2017-02-01
- Contract end date
- 2019-01-31
- UEI
- J3MWGA6WFCG3
- Solicitation number
- PA15-269
- Topic code
- 400
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- In vivo imaging platform for DM1 drug discovery
- Targeted RNA degradation assay for new antiviral drug discovery
- Cell-based RNA degradation assay for C9ALS/FTD drug discovery
- Fluorescent IRE sensor for synucleinopathy drug discovery
- Cell-based assay directly monitoring RNA Polymerase I activity for cancer drug discovery
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Platform for Optimizing Yield and Quality of Therapeutic AAV Vector Manufacturing via Synthetic Helper Genes
- Ultra-low-temperature (6 K) static NMR-DNP for metalloproteins, proteins in cells, and materials
- Dynamical Diffraction Analysis for 3D Electron Crystallography
- Synthetic biology approaches for bio-orthogonal labeling of circular RNAs
- Break Wave lithotripsy to fragment large kidney stones
Research funding history
22 SBIR/STTR records share this UEI (2011–2025). Reported award amounts total $10,266,039. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services, National Science Foundation